AGILERA PHARMA AS

ASActive

Org 928041069Instituttveien 18, 2007 KjellerManufacture of pharmaceutical preparations· NACE 2120Est. 2021 · 4 years old134 employees

Overview Financials People & ownership Related companies

AGILERA PHARMA AS is a Norwegian AS based in Kjeller, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2021, the company has 134 employees and reported revenue of NOK 357,6M in its latest annual filing.

Revenue 2024

NOK 357,6M

+23% vs 2023

EBITDA margin

-6.6%

-321% vs 2023

Net profit 2024

NOK -34,8M

-318% vs 2023

Key ratios

See full ratios →

10.1%

This company

20222024

1.1×

This company

20222024

-23.3%

This company

20222024

EBITDA — year on year

NOK millions

Key figures

Annual report 2024

Revenue	NOK 357,6M	+23%
EBITDA	NOK -23,8M	-321%
Net profit	NOK -34,8M	-318%
Total assets	NOK 149,2M	-5%
Equity	NOK 15M	-70%
Employees	134	—

Contact

Address

Instituttveien 18, 2007 Kjeller

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of AGILERA PHARMA AS?

AGILERA PHARMA AS is registered with Brønnøysundsregistrene under Org 928041069.

What is the revenue of AGILERA PHARMA AS?

AGILERA PHARMA AS reported revenue of NOK 357,6M in 2024.

How many employees does AGILERA PHARMA AS have?

AGILERA PHARMA AS employs 134 people as of the latest annual report.

Who is the CEO of AGILERA PHARMA AS?

Erik Flatmark is the CEO of AGILERA PHARMA AS, in role since 2023.

Who is the chairman of AGILERA PHARMA AS?

Nils Morten Huseby chairs the board of AGILERA PHARMA AS, in role since 2023.

Where is AGILERA PHARMA AS headquartered?

AGILERA PHARMA AS's registered address is Instituttveien 18, 2007 Kjeller.

AGILERA PHARMA AS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AGILERA PHARMA AS

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on AGILERA PHARMA AS